Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a CBP/p300 bromodomain inhibitor and a KRAS inhibitor for the treatment of cancer

Combination of a CBP/p300 bromodomain inhibitor and a KRAS inhibitor for the treatment of cancer

US Patent 12472179 · Granted Nov 18, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic derivatives, pharmaceutical compositions and their use in the treat2025
Heterocyclic derivatives, pharmaceutical compositions and their use in the treat2025
Heterocyclic derivatives, pharmaceutical compositions and their use in the treat2025
Disubstituted alkyne derivatives2025
Next-generation modulators of stimulator of interferon genes (STING)2025
Selective inhibitors of NLRP3 inflammasome2025
Modulators of stimulator of interferon genes (STING)2024
Urea derivatives and methods of use thereof2022
Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases2020
Bispecific HER2 ligands for cancer therapy2018
Inhibitors of AKT activity2015